Resumen
Cichorium intybus, commonly called chicory, has been widely used as a coffee substitute. It display a wide range of natural compounds and medicinally uses in treatment of gastrointestinal disorders. This study synthesized silver nanoparticles (Ci-AgNPs) using C. intybus leaf-derived callus extract to evaluate phytochemical content, antibacterial, antioxidant and anti-proliferative activities against human breast cancer cells (MDA-MB231). The optimal shape, size and stability of Ci-AgNPs was confirmed using UV–visible spectrophotometry, FESEM, EDX, XRD, DLS, Zeta potential, FTIR and sp-ICP-MS studies. The antibacterial activity of Ci-AgNPs was assessed using disk diffusion method against Staphylococcus aureus and Escherichia coli, and they displayed distinct zones of inhibition. Colorimetric phytochemical analysis of Ci-AgNPs revealed their higher total phenolic (TP) and total flavonoid (TF) content. Ci-AgNPs also indicated a high level of antioxidant activity using FRAP and DPPH assays. The Ci-AgNPs were investigated for their anticancer activities on the cancerous MDA-MB231 cells viability and apoptosis using MTT and flow cytometry, respectively. Ci-AgNPs showed dose dependent cytotoxicity against MDA-MB231 cells with IC50 value of 187.6 μg/mL at 48 h through induction of apoptosis. The biocompatibility test showed that Ci-AgNPs induced neglectable cytotoxicity (lower than 3 %) toward human erythrocytes. This is the first study that reports the bio-callus mediated synthesis of silver nanoparticle using C. intybus callus extract which provided a promising anticancer activity against human breast cancer MDA-MB231 cells and therefore could be used as an alternative and interesting benign strategy for biosynthesis of silver nanoparticles useful in cancer therapy.
Idioma original | English |
---|---|
Número de artículo | 122062 |
Publicación | International Journal of Pharmaceutics |
Volumen | 625 |
DOI | |
Estado | Published - sep. 25 2022 |
Nota bibliográfica
Funding Information:This work has been supported financially by Alzahra University, Tehran, Iran, under a postdoctoral scholar (Grant No. 500-3-589).
Publisher Copyright:
© 2022
ASJC Scopus Subject Areas
- Pharmaceutical Science
PubMed: MeSH publication types
- Journal Article